Bioimpedance Analyzers Market

Bioimpedance Analyzers Market Size, Share, Growth Analysis, By Product(Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers), By Modality(Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers), By Usage Type(Consumer-grade Bioimpedance Analyzers, Professional-grade Bioimpedance Analyzers), By Application(Whole-body Measurement, Segmental Body Measurement), By End User(Hospitals & Clinics, Fitness Clubs & Wellness Centers), By Region(North America, Europe) - Industry Forecast 2024-2031

Report ID: UCMIG35A2889 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Bioimpedance Analyzers Market Insights

Market Overview:

The worldwide market for bioimpedance analyzers, in terms of its financial value, was approximately valued at $564 million in 2023, with potential growth to reach $927 million by 2028. This anticipated expansion signifies a consistent Compound Annual Growth Rate (CAGR) of 10.4% from 2023 to 2028.

Bioimpedance Analyzers Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
GET FREE SAMPLE

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

Segmentation Analysis:

The Bioimpedance Analyzers Market is segmented by Product, Modality, Usage Type, Application, End User, Region. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

Bioimpedance Analyzers Market Basis Point Share Analysis, 2021 Vs. 2028
BasisPointShareAnalysis
To get detailed analysis on all segments
BUY NOW
  • Based on Product the market is segmented as, Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers, Dual-frequency Bioimpedance Analyzer
  • Based on Modality the market is segmented as, Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers
  • Based on Usage Type the market is segmented as, Consumer-grade Bioimpedance Analyzers, Professional-grade Bioimpedance Analyzers
  • Based on Application the market is segmented as, Whole-body Measurement, Segmental Body Measurement
  • Based on End User the market is segmented as, Hospitals & Clinics, Fitness Clubs & Wellness Centers, Home Users, Other End Users
  • Based on Region the market is segmented as, North America, Europe, Asia Pacific, Rest of the World, Key Players, OMRON Corporation, Tanita Corporation, InBody, RJL Systems

Regional Analysis:

Bioimpedance Analyzers Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.

Bioimpedance Analyzers Market Attractiveness Analysis, By Region 2020-2028
AttractivenessAnalysis
To know more about the market opportunities by region and country, click here to
REQUEST FREE CUSTOMIZATION

Bioimpedance Analyzers Market : Risk Analysis

SkyQuest's expert analysts have conducted a risk analysis to understand the impact of external extremities on Bioimpedance Analyzers Market. We analyzed how geopolitical influence, natural disasters, climate change, legal scenario, economic impact, trade & economic policies, social & ethnic concerns, and demographic changes might affect Bioimpedance Analyzers Market's supply chain, distribution, and total revenue growth.

Competitive landscaping:

To understand the competitive landscape, we are analyzing key Bioimpedance Analyzers Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Bioimpedance Analyzers Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

  • bioimpedance analyzers market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals and fitness clubs, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market.
  • Bioimpedance Analyzers Market Dynamics
  • DRIVER: Increasing prevalence of lifestyle diseases
  • The rising prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes, is probably due to unhealthy lifestyles, such as sedentary work environments, eating more junk food, and increased mobility automation.
  • By 2035, more than 4 billion people, over 50% of the global population, may be affected by obesity, up from 2.6 billion in 2020. Obesity rates, with a BMI of 30 or higher, are anticipated to rise from 14% to 24%, impacting nearly 2 billion individuals. Urgent action is needed to address this global health challenge.
  • RESTRAINT: High cost of analyzers
  • The smaller healthcare facilities, clinics, and resource-constrained regions will get limited by the high cost of analyzers. Depending on the features, capabilities, and frequency, bioimpedance analyzers can range in pricing. For some healthcare facilities, fitness centers, and research institutions, especially smaller or resource-constrained organizations, the cost of acquiring and maintaining these devices can be a significant barrier. The price of bioimpedance analyzers can range from USD 2,000- USD 30,000.
  • OPPORTUNITY: Integration with wearable devices
  • Wearable devices, such as fitness trackers or smartwatches, to monitor body composition and hydration status could be integrated with bioimpedance analyzers. This integration will allow for real-time data collection and analysis, which will enable individuals to track their health parameters throughout the day and make informed decisions about their lifestyle and behavior.
  • CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers
  • Although valuable information about body composition and hydration status can be obtained with bioimpedance analyzers, their accuracy may vary depending on age, gender, body type, and hydration level. They may not be as accurate as gold standard methods like DEXA or hydrostatic weighing in some cases. The number represents an estimate of the total body fat percentage, even though one gets an accurate reading on a bioimpedance scale. Most of the scales also cannot tell where fat is located in the body. Even though many factors can affect reading accuracy, a regular BIA scale can show changes in body fat over time. However, the obtained number may not be accurate but can still track changes to the body composition. This limitation can deter healthcare professionals and researchers who require exact measurements.
  • BIOIMPEDANCE ANALYZERS ECOSYSTEM
  • Prominent companies in this market include well-established, financially stable manufacturers of bioimpedance analyzers. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks.
  • In 2022, multi-frequency bioimpedance analyzers segment to observe the highest growth rate of the bioimpedance analyzers industry, by product.
  • Based on product, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share can be attributed to features like advanced tissue differentiation and integration with other technologies.
  • “In 2022, segmental body measurement segment to dominate the bioimpedance analyzers industry, by application.
  • Based on application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment accounted for the largest share of the market in 2022. Also, this segment is estimated to witness the highest growth during the forecast period. The large share is due to tracking changes in specific body segments by athletes and monitoring the effectiveness of the training programs.
  • In 2022, North America to dominate in bioimpedance analyzers industry.
  • The global bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to the high promotion of healthy lifestyles, sedentary work life, and large population consuming junk food.
  • Recent Developments of Bioimpedance Analyzers Industry
  • In 2023, Bodystat Ltd. (UK) launched the Multiscan 5000, which incorporates the latest state-of-the-art bioelectrical impedance spectroscopy (BIS) technology based on direct digital synthesis, digital signal processing, and active shielding technology.
  • In 2023, InBody Co., Ltd. (South Korea) announced it would supply the US Marine Corps with body composition analysis devices. The US Marine Corps announced refinements in its body composition assessment methods using the InBody 770 analyzer.
  • In 2022, InBody Co., Ltd. (South Korea) partnered with iLoveKickboxing (US). The partnership offered iLoveKickboxing members access to high-quality data about their body fat percentage, muscle mass, and other biometrics. It enabled them to monitor changes over time via the InBody App.
  • KEY MARKET SEGMENTS
  • By Product
  • Multi-frequency Bioimpedance Analyzers
  • Single-frequency Bioimpedance Analyzers
  • Dual-frequency Bioimpedance Analyzer
  • By Modality
  • Wired Bioimpedance Analyzers
  • Wireless Bioimpedance Analyzers
  • By Usage Type
  • Consumer-grade Bioimpedance Analyzers
  • Professional-grade Bioimpedance Analyzers
  • By Application
  • Whole-body Measurement
  • Segmental Body Measurement
  • By End User
  • Hospitals & Clinics
  • Fitness Clubs & Wellness Centers
  • Home Users
  • Other End Users
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • Key Players
  • OMRON Corporation
  • Tanita Corporation
  • InBody
  • RJL Systems
  • Seca GmbH & Co. KG

SkyQuest's Expertise:

The Bioimpedance Analyzers Market is being analyzed by SkyQuest's analysts with the help of 20+ scheduled Primary interviews from both the demand and supply sides. We have already invested more than 250 hours on this report and are still refining our date to provide authenticated data to your readers and clients. Exhaustive primary and secondary research is conducted to collect information on the market, peer market, and parent market.

Our cross-industry experts and revenue-impact consultants at SkyQuest enable our clients to convert market intelligence into actionable, quantifiable results through personalized engagement.

Scope Of Report

Report Attribute Details
The base year for estimation 2021
Historical data 2016 – 2022
Forecast period 2022 – 2028
Report coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered
  • By Product - Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers, Dual-frequency Bioimpedance Analyzer
  • By Modality - Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers
  • By Usage Type - Consumer-grade Bioimpedance Analyzers, Professional-grade Bioimpedance Analyzers
  • By Application - Whole-body Measurement, Segmental Body Measurement
  • By End User - Hospitals & Clinics, Fitness Clubs & Wellness Centers, Home Users, Other End Users
  • By Region - North America, Europe, Asia Pacific, Rest of the World, Key Players, OMRON Corporation, Tanita Corporation, InBody, RJL Systems
Regional scope North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
Country scope U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, South Africa
Key companies profiled
  • bioimpedance analyzers market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals and fitness clubs, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market.
  • Bioimpedance Analyzers Market Dynamics
  • DRIVER: Increasing prevalence of lifestyle diseases
  • The rising prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes, is probably due to unhealthy lifestyles, such as sedentary work environments, eating more junk food, and increased mobility automation.
  • By 2035, more than 4 billion people, over 50% of the global population, may be affected by obesity, up from 2.6 billion in 2020. Obesity rates, with a BMI of 30 or higher, are anticipated to rise from 14% to 24%, impacting nearly 2 billion individuals. Urgent action is needed to address this global health challenge.
  • RESTRAINT: High cost of analyzers
  • The smaller healthcare facilities, clinics, and resource-constrained regions will get limited by the high cost of analyzers. Depending on the features, capabilities, and frequency, bioimpedance analyzers can range in pricing. For some healthcare facilities, fitness centers, and research institutions, especially smaller or resource-constrained organizations, the cost of acquiring and maintaining these devices can be a significant barrier. The price of bioimpedance analyzers can range from USD 2,000- USD 30,000.
  • OPPORTUNITY: Integration with wearable devices
  • Wearable devices, such as fitness trackers or smartwatches, to monitor body composition and hydration status could be integrated with bioimpedance analyzers. This integration will allow for real-time data collection and analysis, which will enable individuals to track their health parameters throughout the day and make informed decisions about their lifestyle and behavior.
  • CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers
  • Although valuable information about body composition and hydration status can be obtained with bioimpedance analyzers, their accuracy may vary depending on age, gender, body type, and hydration level. They may not be as accurate as gold standard methods like DEXA or hydrostatic weighing in some cases. The number represents an estimate of the total body fat percentage, even though one gets an accurate reading on a bioimpedance scale. Most of the scales also cannot tell where fat is located in the body. Even though many factors can affect reading accuracy, a regular BIA scale can show changes in body fat over time. However, the obtained number may not be accurate but can still track changes to the body composition. This limitation can deter healthcare professionals and researchers who require exact measurements.
  • BIOIMPEDANCE ANALYZERS ECOSYSTEM
  • Prominent companies in this market include well-established, financially stable manufacturers of bioimpedance analyzers. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks.
  • In 2022, multi-frequency bioimpedance analyzers segment to observe the highest growth rate of the bioimpedance analyzers industry, by product.
  • Based on product, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share can be attributed to features like advanced tissue differentiation and integration with other technologies.
  • “In 2022, segmental body measurement segment to dominate the bioimpedance analyzers industry, by application.
  • Based on application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment accounted for the largest share of the market in 2022. Also, this segment is estimated to witness the highest growth during the forecast period. The large share is due to tracking changes in specific body segments by athletes and monitoring the effectiveness of the training programs.
  • In 2022, North America to dominate in bioimpedance analyzers industry.
  • The global bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to the high promotion of healthy lifestyles, sedentary work life, and large population consuming junk food.
  • Recent Developments of Bioimpedance Analyzers Industry
  • In 2023, Bodystat Ltd. (UK) launched the Multiscan 5000, which incorporates the latest state-of-the-art bioelectrical impedance spectroscopy (BIS) technology based on direct digital synthesis, digital signal processing, and active shielding technology.
  • In 2023, InBody Co., Ltd. (South Korea) announced it would supply the US Marine Corps with body composition analysis devices. The US Marine Corps announced refinements in its body composition assessment methods using the InBody 770 analyzer.
  • In 2022, InBody Co., Ltd. (South Korea) partnered with iLoveKickboxing (US). The partnership offered iLoveKickboxing members access to high-quality data about their body fat percentage, muscle mass, and other biometrics. It enabled them to monitor changes over time via the InBody App.
  • KEY MARKET SEGMENTS
  • By Product
  • Multi-frequency Bioimpedance Analyzers
  • Single-frequency Bioimpedance Analyzers
  • Dual-frequency Bioimpedance Analyzer
  • By Modality
  • Wired Bioimpedance Analyzers
  • Wireless Bioimpedance Analyzers
  • By Usage Type
  • Consumer-grade Bioimpedance Analyzers
  • Professional-grade Bioimpedance Analyzers
  • By Application
  • Whole-body Measurement
  • Segmental Body Measurement
  • By End User
  • Hospitals & Clinics
  • Fitness Clubs & Wellness Centers
  • Home Users
  • Other End Users
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • Key Players
  • OMRON Corporation
  • Tanita Corporation
  • InBody
  • RJL Systems
  • Seca GmbH & Co. KG
Customization scope Free report customization (15% Free customization) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Reap the benefits of customized purchase options to fit your specific research requirements.

Objectives of the Study

  • To forecast the market size, in terms of value, for various segments with respect to five main regions, namely, North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
  • To provide detailed information regarding the major factors influencing the growth of the Market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets with respect to the individual growth trends, future prospects, and contribution to the total market
  • To provide a detailed overview of the value chain and analyze market trends with the Porter's five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth Segments
  • To identify the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive development such as joint ventures, mergers and acquisitions, new product launches and development, and research and development in the market

What does this Report Deliver?

  • Market Estimation for 20+ Countries
  • Historical data coverage: 2016 to 2022
  • Growth projections: 2022 to 2028
  • SkyQuest's premium market insights: Innovation matrix, IP analysis, Production Analysis, Value chain analysis, Technological trends, and Trade analysis
  • Customization on Segments, Regions, and Company Profiles
  • 100+ tables, 150+ Figures, 10+ matrix
  • Global and Country Market Trends
  • Comprehensive Mapping of Industry Parameters
  • Attractive Investment Proposition
  • Competitive Strategies Adopted by Leading Market Participants
  • Market drivers, restraints, opportunities, and its impact on the market
  • Regulatory scenario, regional dynamics, and insights of leading countries in each region
  • Segment trends analysis, opportunity, and growth
  • Opportunity analysis by region and country
  • Porter's five force analysis to know the market's condition
  • Pricing analysis
  • Parent market analysis
  • Product portfolio benchmarking

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Bioimpedance Analyzers Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Bioimpedance Analyzers Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)
  • bioimpedance analyzers market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals and fitness clubs, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Bioimpedance Analyzers Market Dynamics
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • DRIVER: Increasing prevalence of lifestyle diseases
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The rising prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes, is probably due to unhealthy lifestyles, such as sedentary work environments, eating more junk food, and increased mobility automation.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By 2035, more than 4 billion people, over 50% of the global population, may be affected by obesity, up from 2.6 billion in 2020. Obesity rates, with a BMI of 30 or higher, are anticipated to rise from 14% to 24%, impacting nearly 2 billion individuals. Urgent action is needed to address this global health challenge.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • RESTRAINT: High cost of analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The smaller healthcare facilities, clinics, and resource-constrained regions will get limited by the high cost of analyzers. Depending on the features, capabilities, and frequency, bioimpedance analyzers can range in pricing. For some healthcare facilities, fitness centers, and research institutions, especially smaller or resource-constrained organizations, the cost of acquiring and maintaining these devices can be a significant barrier. The price of bioimpedance analyzers can range from USD 2,000- USD 30,000.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • OPPORTUNITY: Integration with wearable devices
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Wearable devices, such as fitness trackers or smartwatches, to monitor body composition and hydration status could be integrated with bioimpedance analyzers. This integration will allow for real-time data collection and analysis, which will enable individuals to track their health parameters throughout the day and make informed decisions about their lifestyle and behavior.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Although valuable information about body composition and hydration status can be obtained with bioimpedance analyzers, their accuracy may vary depending on age, gender, body type, and hydration level. They may not be as accurate as gold standard methods like DEXA or hydrostatic weighing in some cases. The number represents an estimate of the total body fat percentage, even though one gets an accurate reading on a bioimpedance scale. Most of the scales also cannot tell where fat is located in the body. Even though many factors can affect reading accuracy, a regular BIA scale can show changes in body fat over time. However, the obtained number may not be accurate but can still track changes to the body composition. This limitation can deter healthcare professionals and researchers who require exact measurements.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • BIOIMPEDANCE ANALYZERS ECOSYSTEM
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Prominent companies in this market include well-established, financially stable manufacturers of bioimpedance analyzers. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In 2022, multi-frequency bioimpedance analyzers segment to observe the highest growth rate of the bioimpedance analyzers industry, by product.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Based on product, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share can be attributed to features like advanced tissue differentiation and integration with other technologies.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • “In 2022, segmental body measurement segment to dominate the bioimpedance analyzers industry, by application.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Based on application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment accounted for the largest share of the market in 2022. Also, this segment is estimated to witness the highest growth during the forecast period. The large share is due to tracking changes in specific body segments by athletes and monitoring the effectiveness of the training programs.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In 2022, North America to dominate in bioimpedance analyzers industry.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • The global bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to the high promotion of healthy lifestyles, sedentary work life, and large population consuming junk food.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Recent Developments of Bioimpedance Analyzers Industry
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In 2023, Bodystat Ltd. (UK) launched the Multiscan 5000, which incorporates the latest state-of-the-art bioelectrical impedance spectroscopy (BIS) technology based on direct digital synthesis, digital signal processing, and active shielding technology.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In 2023, InBody Co., Ltd. (South Korea) announced it would supply the US Marine Corps with body composition analysis devices. The US Marine Corps announced refinements in its body composition assessment methods using the InBody 770 analyzer.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • In 2022, InBody Co., Ltd. (South Korea) partnered with iLoveKickboxing (US). The partnership offered iLoveKickboxing members access to high-quality data about their body fat percentage, muscle mass, and other biometrics. It enabled them to monitor changes over time via the InBody App.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • KEY MARKET SEGMENTS
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Product
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Multi-frequency Bioimpedance Analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Single-frequency Bioimpedance Analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Dual-frequency Bioimpedance Analyzer
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Modality
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Wired Bioimpedance Analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Wireless Bioimpedance Analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Usage Type
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Consumer-grade Bioimpedance Analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Professional-grade Bioimpedance Analyzers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Application
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Whole-body Measurement
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Segmental Body Measurement
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By End User
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Hospitals & Clinics
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Fitness Clubs & Wellness Centers
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Home Users
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Other End Users
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • By Region
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • North America
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Europe
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Asia Pacific
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Rest of the World
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Key Players
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • OMRON Corporation
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Tanita Corporation
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • InBody
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • RJL Systems
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Seca GmbH & Co. KG
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments

Methodology

For the Bioimpedance Analyzers Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Bioimpedance Analyzers Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Bioimpedance Analyzers Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Bioimpedance Analyzers Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for Bioimpedance Analyzers was estimated to be valued at US$ XX Mn in 2021.

The global Bioimpedance Analyzers Market is estimated to grow at a CAGR of XX% by 2028.

The global Bioimpedance Analyzers Market is segmented on the basis of Product, Modality, Usage Type, Application, End User, Region.

Based on region, the global Bioimpedance Analyzers Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global Bioimpedance Analyzers Market are bioimpedance analyzers market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals and fitness clubs, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market., Bioimpedance Analyzers Market Dynamics, DRIVER: Increasing prevalence of lifestyle diseases, The rising prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes, is probably due to unhealthy lifestyles, such as sedentary work environments, eating more junk food, and increased mobility automation., By 2035, more than 4 billion people, over 50% of the global population, may be affected by obesity, up from 2.6 billion in 2020. Obesity rates, with a BMI of 30 or higher, are anticipated to rise from 14% to 24%, impacting nearly 2 billion individuals. Urgent action is needed to address this global health challenge., RESTRAINT: High cost of analyzers, The smaller healthcare facilities, clinics, and resource-constrained regions will get limited by the high cost of analyzers. Depending on the features, capabilities, and frequency, bioimpedance analyzers can range in pricing. For some healthcare facilities, fitness centers, and research institutions, especially smaller or resource-constrained organizations, the cost of acquiring and maintaining these devices can be a significant barrier. The price of bioimpedance analyzers can range from USD 2,000- USD 30,000., OPPORTUNITY: Integration with wearable devices, Wearable devices, such as fitness trackers or smartwatches, to monitor body composition and hydration status could be integrated with bioimpedance analyzers. This integration will allow for real-time data collection and analysis, which will enable individuals to track their health parameters throughout the day and make informed decisions about their lifestyle and behavior., CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers, Although valuable information about body composition and hydration status can be obtained with bioimpedance analyzers, their accuracy may vary depending on age, gender, body type, and hydration level. They may not be as accurate as gold standard methods like DEXA or hydrostatic weighing in some cases. The number represents an estimate of the total body fat percentage, even though one gets an accurate reading on a bioimpedance scale. Most of the scales also cannot tell where fat is located in the body. Even though many factors can affect reading accuracy, a regular BIA scale can show changes in body fat over time. However, the obtained number may not be accurate but can still track changes to the body composition. This limitation can deter healthcare professionals and researchers who require exact measurements., BIOIMPEDANCE ANALYZERS ECOSYSTEM, Prominent companies in this market include well-established, financially stable manufacturers of bioimpedance analyzers. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks., In 2022, multi-frequency bioimpedance analyzers segment to observe the highest growth rate of the bioimpedance analyzers industry, by product., Based on product, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share can be attributed to features like advanced tissue differentiation and integration with other technologies., “In 2022, segmental body measurement segment to dominate the bioimpedance analyzers industry, by application., Based on application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. The segmental body measurement segment accounted for the largest share of the market in 2022. Also, this segment is estimated to witness the highest growth during the forecast period. The large share is due to tracking changes in specific body segments by athletes and monitoring the effectiveness of the training programs., In 2022, North America to dominate in bioimpedance analyzers industry., The global bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate during the forecast period, primarily due to the high promotion of healthy lifestyles, sedentary work life, and large population consuming junk food. , Recent Developments of Bioimpedance Analyzers Industry, In 2023, Bodystat Ltd. (UK) launched the Multiscan 5000, which incorporates the latest state-of-the-art bioelectrical impedance spectroscopy (BIS) technology based on direct digital synthesis, digital signal processing, and active shielding technology., In 2023, InBody Co., Ltd. (South Korea) announced it would supply the US Marine Corps with body composition analysis devices. The US Marine Corps announced refinements in its body composition assessment methods using the InBody 770 analyzer., In 2022, InBody Co., Ltd. (South Korea) partnered with iLoveKickboxing (US). The partnership offered iLoveKickboxing members access to high-quality data about their body fat percentage, muscle mass, and other biometrics. It enabled them to monitor changes over time via the InBody App., KEY MARKET SEGMENTS, By Product, Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers, Dual-frequency Bioimpedance Analyzer, By Modality, Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers, By Usage Type, Consumer-grade Bioimpedance Analyzers, Professional-grade Bioimpedance Analyzers, By Application, Whole-body Measurement, Segmental Body Measurement, By End User, Hospitals & Clinics, Fitness Clubs & Wellness Centers, Home Users, Other End Users, By Region , North America, Europe, Asia Pacific, Rest of the World, Key Players, OMRON Corporation , Tanita Corporation , InBody , RJL Systems , Seca GmbH & Co. KG.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Bioimpedance Analyzers Market

Report ID: UCMIG35A2683 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Infertility Treatment Devices And Equipment Market
Buy Now GET FREE SAMPLE
Bioimpedance Analyzers Market

Report ID: UCMIR35A2763 | Region: Regional | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

U.S. Surgical Staplers Market
Buy Now GET FREE SAMPLE
Bioimpedance Analyzers Market

Report ID: UCMIG35A2094 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Medical Lasers Market
Buy Now GET FREE SAMPLE
Bioimpedance Analyzers Market

Report ID: UCMIG35A2759 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60

Veterinary Surgical Instrument Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Bioimpedance Analyzers Market

Product ID: UCMIG35A2889

$5,300
BUY NOW GET FREE SAMPLE